About
TSE aims to undertake research that helps public and private organizations to address health issues and improve quality and access to care both in France and around the world. For more than a decade, TSE economists have been studying diverse topics, such as healthcare, innovation, aging, pharmaceutical regulation, food, and nutrition issues. The set of open questions for economists in the health field remains large. Researchers in economics can develop and use new tools to address questions of regulation and the organization of healthcare and innovation.
In 2021, TSE expanded its footprint in this area by creating a Health Center aimed at developing a center of research excellence in the field of health economics. Combining TSE’s own expertise with its private and public partners’ financial support and knowledge, the TSE Health Center supports a variety of work in the field of health economics. It brings together different strands of research in health economics (including health, healthcare, food), and encourages multidisciplinary research projects involving economists and researchers from other related backgrounds (epidemiology, medicine, pharmacy, psychology, biology, etc…).
Main activities
- Scientific production: development of new knowledge in the framework of multi-year research cycles resulting in academic publications and often punctuated by scientific conferences and seminars,
- Dissemination of economic knowledge through the production of outreach materials and the organization of events meant to inform practitioners, policy makers or a wider audience, and the participation of researchers in the public debate in France and internationally.
Research focuses
Pharmaceutical industry and regulation
- Objective: Researchers involved in this program seek to provide the best trade-off between maintaining incentives to innovate (with high rewards to new useful medicines) and financing health care expenses. We study how regulatory rules impact profitability and welfare in an international context, and analyze the role of marketing authorizations, detailing effort in fostering access and diffusion of medicines.
- Program leader: Pierre Dubois works on health economics and the economics of the pharmaceutical sector, industrial organization, micro econometrics, consumer demand.
Innovation in health
- Objective: Research work developed in this area is focused on incentive and privacy issues. It includes the design of analytical models and the testing of predictions with existing empirical and experimental data.
- Program leader: Philippe De Donder works on public economics, regulation, and health economics.
Public healthcare, long term care and aging
- Objective: This program aims to offer a better understanding of the complex relationships between the different insurers, and care providers including practitioners, hospitals, or the pharmaceutical industry. Researchers also study the different forms of financing expenses related to aging and age-related dependency.
- Program leader: Jean-Marie Lozachmeur works on public economics, health economics and industrial organization.
Food and healthy behavior economics
- Objective: Researchers involved in this program study the determinants of food behavior with special attention given to the role of socio-economic factors, peer effects, food availability and prices, and the environment. Our work helps assess the impact of food policies on health and social welfare and understand how businesses and markets respond to policies.
- Program leader: Céline Bonnet works on industrial organization, manufacturers and retailers’ relationships, applied econometrics, consumer behavior. She is a specialist of consumers’ and firms’ behavior in the agrofood chains.
